Cargando…

Low Dose Interleukin-2 Ameliorates Sjögren’s Syndrome in a Murine Model

Sjögren’s syndrome (SS) is a systemic autoimmune disease with no efficient treatment, and it is associated with dysregulated immune cells and impaired interleukin (IL)-2 signaling. IL-2 is critical for the development and maintenance of Treg cells. The use of low dose of IL-2 (LDIL-2) in the treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yifan, Feng, Ruiling, Cheng, Gong, Huang, Bo, Tian, Jiayi, Gan, Yuzhou, Jin, Yuebo, Miao, Miao, Zhang, Xia, Sun, Xiaolin, He, Jing, Li, Zhanguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160330/ https://www.ncbi.nlm.nih.gov/pubmed/35665339 http://dx.doi.org/10.3389/fmed.2022.887354

Ejemplares similares

Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome: A Randomized Clinical Trial
por: He, Jing, et al.
Publicado: (2022)

Treatment of Active Idiopathic Inflammatory Myopathies by Low-Dose Interleukin-2: A Prospective Cohort Pilot Study
por: Miao, Miao, et al.
Publicado: (2021)

Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis
por: Zhang, Xia, et al.
Publicado: (2021)

Increased Interleukin-17F is Associated with Elevated Autoantibody Levels and More Clinically Relevant Than Interleukin-17A in Primary Sjögren's Syndrome
por: Gan, Yuzhou, et al.
Publicado: (2017)

Therapeutic potential of targeting Tfr/Tfh cell balance by low-dose-IL-2 in active SLE: a post hoc analysis from a double-blind RCT study
por: Miao, Miao, et al.
Publicado: (2021)

Comparison of the deep immune profiling of B cell subsets between healthy adults and Sjögren’s syndrome
por: Feng, Ruiling, et al.
Publicado: (2022)

Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study
por: Zhufeng, Yunzhi, et al.
Publicado: (2022)

Tissue-Specific Autoantibodies Improve Diagnosis of Primary Sjögren's Syndrome in the Early Stage and Indicate Localized Salivary Injury
por: Jin, Yuebo, et al.
Publicado: (2019)

Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial
por: Zhang, Xiaoying, et al.
Publicado: (2022)

The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sjögren's Syndrome
por: Li, Linbo, et al.
Publicado: (2015)

A Rare Case of Neurosarcoidosis Overlapped with Sjogren’s Syndrome
por: Cai, Wenxin, et al.
Publicado: (2022)

Sjogren's Syndrome: Clinical Benefits of Low-dose Naltrexone Therapy
por: Zashin, Scott
Publicado: (2019)

Symptomatic hyponatremia induced by low-dose cyclophosphamide in patient with systemic lupus erythematosus: A case report
por: Chen, Jiali, et al.
Publicado: (2020)

Low-dose interleukin-2 can improve salivary secretion but not lymphocyte infiltration of salivary glands in a murine model of Sjögren’s syndrome
por: Wen, Junsong, et al.
Publicado: (2022)

Hypomyopathic Dermatomyositis with Refractory Dermatitis Treated by Low-dose IL-2
por: Miao, Miao, et al.
Publicado: (2020)

Retrospective analysis of low-dose interleukin-2 therapy on chronic autoimmune thyroid disease with concurrent systemic lupus erythematosus
por: Wang, Naidi, et al.
Publicado: (2023)

Sjogren's Syndrome and Clinical Benefits of Low-Dose Naltrexone Therapy: Additional Case Reports
por: Zashin, Scott
Publicado: (2020)

Double Negative B Cell Is Associated With Renal Impairment in Systemic Lupus Erythematosus and Acts as a Marker for Nephritis Remission
por: You, Xujie, et al.
Publicado: (2020)

Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sjögren's syndrome by modulating the balance of Treg and Th17 cells
por: Li, Boya, et al.
Publicado: (2021)

Low-dose IL-2 mitigates glucocorticoid-induced Treg impairment and promotes improvement of SLE
por: Zhou, Haotian, et al.
Publicado: (2023)

Dental follicle mesenchymal stem cells ameliorated glandular dysfunction in Sjögren’s syndrome murine model
por: Genç, Deniz, et al.
Publicado: (2022)

Editorial: Management of Sjögren's Syndrome
por: Alunno, Alessia, et al.
Publicado: (2022)

Lymphoma and Lymphomagenesis in Primary Sjögren’s Syndrome
por: Alunno, Alessia, et al.
Publicado: (2018)

Teasaponin Ameliorates Murine Colitis by Regulating Gut Microbiota and Suppressing the Immune System Response
por: Yang, Huan, et al.
Publicado: (2020)

Amelioration of Murine Colitis by Attenuated Salmonella choleraesuis Encoding Interleukin-19
por: Chen, Shih-Yao, et al.
Publicado: (2023)

Olfactory Ecto-mesenchymal Stem Cell-derived Exosomes Ameliorate Murine Sjögren’s Syndrome via Suppressing Tfh Cell Response
por: Rui, Ke, et al.
Publicado: (2022)

Tph Cells Expanded in Primary Sjögren’s Syndrome
por: Chen, Weiqian, et al.
Publicado: (2022)

Sex differences in comorbidities associated with Sjögren's disease
por: Bruno, Katelyn A., et al.
Publicado: (2022)

Salivary gland ultrasonography in primary Sjögren’s syndrome from diagnosis to clinical stratification: a multicentre study
por: Zhang, Xia, et al.
Publicado: (2021)

The association of periodontal diseases and Sjogren’s syndrome: A systematic review and meta-analysis
por: Yang, Bo, et al.
Publicado: (2023)

Factors Associated With Renal Involvement in Primary Sjögren's Syndrome: A Meta-Analysis
por: Hong, Ruping, et al.
Publicado: (2020)

Editorial: Novel biomarkers for clinical and molecular stratification of organ involvement in rheumatic diseases
por: Sun, Xiaolin, et al.
Publicado: (2023)

Clinical Analysis: Aqueous-Deficient and Meibomian Gland Dysfunction in Patients With Primary Sjogren's Syndrome
por: Wang, Yi, et al.
Publicado: (2019)

Management of Sjögren's Syndrome: Present Issues and Future Perspectives
por: Vitali, Claudio, et al.
Publicado: (2021)

Recent Advances of Salivary Gland Biopsy in Sjögren's Syndrome
por: Liao, Rui, et al.
Publicado: (2022)

Immune infiltration analysis reveals immune cell signatures in salivary gland tissue of primary Sjögren’s syndrome
por: Gong, Hongxiao, et al.
Publicado: (2023)

Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren’s syndrome by modulating the function of myeloid-derived suppressor cells
por: Rui, Ke, et al.
Publicado: (2021)

Mucosal administration of α-fodrin inhibits experimental Sjögren's syndrome autoimmunity
por: He, Jing, et al.
Publicado: (2008)

Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
por: He, Jing, et al.
Publicado: (2020)

GABA Administration Ameliorates Sjogren’s Syndrome in Two Different Mouse Models
por: Song, Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9gk524ktmlljj57ahh2m02sjth